| Theme | Current Status and Future Perspectives of Endoscopic Screening | |
|---|---|---|
| Title | Current Status and Future Prospect of Preemptive Medicine with the Aim to Reduce Morbidity and Mortality Associated with Colorectal Cancer | |
| Publish Date | 2017/11 | |
| Author | Hideki Ishikawa | Department of Molecular‒Targeting Cancer Prevention, Kyoto Prefectural University of Medicine |
| [ Summary ] | This paper describes the measures used in preventing colorectal cancer based on population and high‒risk strategies, focusing on recent preemptive medicine studies to determine the high‒risk strategy. A number of studies regarding the use of aspirin in presumably preventing colorectal cancer have been conducted. However, considering the risks and other factors involved, aspirin has not yet been clinically used in Japan. Using genetic polymorphisms, several clinical studies incorporating the preemptive medicine policies and aspirin application are ongoing to establish an effective method in preventing colorectal cancer. Colorectal cancer morbidity is expected to dramatically decrease using preemptive medicine in the near future. |
|